TrialObesity (Silver Spring, Md.)2026

Oral GLP-1RA TERN-601 for Adults With Obesity/Overweight: Placebo-Controlled, Multiple-Ascending-Dose, Phase 1 and 2 Studies.

W Timothy Garvey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.